Globe Newswire05.02.19
Lantos Technologies announced the U.S. release of the industry’s only U.S. Food and Drug Administration (FDA)-510K cleared, 3D ear scanning system. Built upon its MIT roots, with more than 70 technology patents, the Lantos system transforms the process of providing personalized hearing solutions. With more than 22,000 scans performed and over 4,700 individuals now fitted with custom devices, Lantos has demonstrated the value of 3D ear scanning to patients, clinicians and manufacturers.
From hearing aids to hearing protection, and professional to consumer audio devices, this technology gives audiologists a proven path to provide patient care and modernize their practice.
Dr. Brian Fligor, a current private practice owner and advisor to Lantos Technologies, commented, “I have long been an advocate for the benefits of custom hearing solutions, but after working with patients for 20 years, I am all too familiar with the limitations of earmold impressions. Ear scanning with the Lantos system removes the historical limitations of the process and empowers both me and my staff to give patients the optimal personalized hearing solutions they deserve. I’m proud to deliver this unique patient experience, which differentiates my practice.”
A departure from the routine of traditional silicone earmold impressions, Lantos leverages patented membrane-based scanning technology that captures over one million data points from the outer ear to within 4mm of the eardrum in just one scan. That detailed ear scan data is captured in a user-friendly digital workflow engine and provided to partners for rapid manufacturing via the cloud. The result is a personalized hearing solution, customized exactly to the patient’s precise needs and anatomy, delivered in less time.
“The advancements in hearing aid technologies have been impressive in recent years, but audiologists and their patients are challenged to fully realize them because earmold impressions are inefficient and ineffective. It is time to supplant earmold impressions and make personalized hearing a priority by embracing technologies that enable customization without sacrificing quality or patient experience,” said John Bojanowski, CEO of Lantos Technologies.
While audiologists and patients agree that the optimal process for creating earmolds is through a 3D scan, proper training and support is a critical component to learn any new clinical skill. Led by a team of audiologists, Lantos provides a three-part training program that includes online courses, in-person training, and additional events. Upon completion of the training program, practices streamline their ordering process by immediately sending scans to preferred manufacturer partners for faster and more precise production.
Lantos Technologies is setting a new standard for audiology with the only commercially available, FDA-cleared 3D ear scanning system. Using a membrane-based contact scanning method built from breakthrough MIT technology and protected by over 70 patents, the Lantos 3D Ear Scanning System delivers a comfortable and personalized patient experience. After capturing more than one million unique data points per ear, Lantos' digital workflow ensures the efficient delivery of customized hearing devices. The company is led by a team of innovators and is based in Wilmington, Mass.
From hearing aids to hearing protection, and professional to consumer audio devices, this technology gives audiologists a proven path to provide patient care and modernize their practice.
Dr. Brian Fligor, a current private practice owner and advisor to Lantos Technologies, commented, “I have long been an advocate for the benefits of custom hearing solutions, but after working with patients for 20 years, I am all too familiar with the limitations of earmold impressions. Ear scanning with the Lantos system removes the historical limitations of the process and empowers both me and my staff to give patients the optimal personalized hearing solutions they deserve. I’m proud to deliver this unique patient experience, which differentiates my practice.”
A departure from the routine of traditional silicone earmold impressions, Lantos leverages patented membrane-based scanning technology that captures over one million data points from the outer ear to within 4mm of the eardrum in just one scan. That detailed ear scan data is captured in a user-friendly digital workflow engine and provided to partners for rapid manufacturing via the cloud. The result is a personalized hearing solution, customized exactly to the patient’s precise needs and anatomy, delivered in less time.
“The advancements in hearing aid technologies have been impressive in recent years, but audiologists and their patients are challenged to fully realize them because earmold impressions are inefficient and ineffective. It is time to supplant earmold impressions and make personalized hearing a priority by embracing technologies that enable customization without sacrificing quality or patient experience,” said John Bojanowski, CEO of Lantos Technologies.
While audiologists and patients agree that the optimal process for creating earmolds is through a 3D scan, proper training and support is a critical component to learn any new clinical skill. Led by a team of audiologists, Lantos provides a three-part training program that includes online courses, in-person training, and additional events. Upon completion of the training program, practices streamline their ordering process by immediately sending scans to preferred manufacturer partners for faster and more precise production.
Lantos Technologies is setting a new standard for audiology with the only commercially available, FDA-cleared 3D ear scanning system. Using a membrane-based contact scanning method built from breakthrough MIT technology and protected by over 70 patents, the Lantos 3D Ear Scanning System delivers a comfortable and personalized patient experience. After capturing more than one million unique data points per ear, Lantos' digital workflow ensures the efficient delivery of customized hearing devices. The company is led by a team of innovators and is based in Wilmington, Mass.